Clinical Trial Update: Clinical Trial of TQC2938 Injection in Patients With Seasonal Allergic Rhinitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of TQC2938 injection for seasonal allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• TQC2938

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED